Back to results
US 2024/0043382 A1Published application
Modified indole alkaloids for therapeutic uses
AssigneeCompass Pathfinder Limited
InventorRyan PROTZKO
Life of this patent
Estimating the term…
Abstract
Disclosed herein are enzymatic and modified host cell methods for prepared modified indole alkaloids. Also disclosed herein are modified indole alkaloids and their therapeutic use for treating diseases and disorders.
Claims66
A compound of Formula (Ia):
- or a pharmaceutically acceptable salt thereof, wherein,
- R1 and R10 are independently selected from hydrogen, C1-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
- R8 is —CR′2—, wherein each R′ is independently selected from hydrogen, halo, haloalkyl, alkoxy, haloalkoxy, and amine;
- n is selected from 2, 3, and 4;
- R9 is selected from C2-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, —NO2, and 3- to 8-membered heterocycle, and wherein 3- to 8-membered heterocycle is optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
- R2 is selected from hydrogen, halogen, C1-C6 alkyl, and C1-C6 haloalkyl;
- R4, R5, R6, and R7 are each independently selected from hydrogen, C1-C6 alkyl, A, J, Q, and X;
- A is
- J is
- Q is
- X is selected from glucose, xylose, galactose, rhamnose, rutinose, and disaccharide;
- R13 is selected from hydrogen, and C1-C6 alkyl optionally substituted with one or more substituents independently selected from C1-C6 alkyl, oxo, halo, —OMe, —CN, —NH2, and —NO2;
- R14 is selected from C1-C6 alkyl and C2-C6 alkenyl, wherein C1-C6 alkyl and C2-C6 alkenyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
- or R13 and R14 taken together with the atom to which they are attached to form a substituted or unsubstituted C3-C8cycloalkyl or substituted or unsubstituted 3- to 8-membered heterocycloalkyl having 1 or 2 heteroatoms each independently selected from N, O, and S;
- R15 is selected from C1-C6 alkylene and C2-C6 alkenylene, wherein C1-C6 alkylene and C2-C6 alkenylene are optionally substituted with one or more substituents independently selected from C1-C6 alkyl, halo, —OMe, —CN, —NH2, and —NO2;
- and
- wherein at least one of R4, R5, R6, and R7 is A, J, Q, or X.
14 more elements
A method of treating a disease or disorder in a subject in need thereof comprising administering a compound of Formula (Ia):
- or a pharmaceutically acceptable salt thereof, wherein,
- R1 and R10 are independently selected from hydrogen, C1-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
- R8 is —CR′2—, wherein each R′ is independently selected from hydrogen, halo, haloalkyl, alkoxy, haloalkoxy, and amine;
- n is selected from 2, 3, and 4;
- R9 is selected from C2-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, —NO2, and 3- to 8-membered heterocycle, and wherein 3- to 8-membered heterocycle is optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
- R2 is selected from hydrogen, halogen, C1-C6 alkyl, and C1-C6 haloalkyl;
- R4, R5, R6, and R7 are each independently selected from hydrogen, C1-C6 alkyl, A, J, Q, and X;
- A is
- J is
- Q is
- X is selected from glucose, xylose, galactose, rhamnose, rutinose, and disaccharide;
- R13 is selected from hydrogen, and C1-C6 alkyl optionally substituted with one or more substituents independently selected from C1-C6 alkyl, oxo, halo, —OMe, —CN, —NH2, and —NO2;
- R14 is selected from C1-C6 alkyl and C2-C6 alkenyl, wherein C1-C6 alkyl and C2-C6 alkenyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
- or R13 and R14 taken together with the atom to which they are attached to form a substituted or unsubstituted C3-C8cycloalkyl or substituted or unsubstituted 3- to 8-membered heterocycloalkyl having 1 or 2 heteroatoms each independently selected from N, O, and S;
- R15 is selected from C1-C6 alkylene and C2-C6 alkenylene, wherein C1-C6 alkylene and C2-C6 alkenylene are optionally substituted with one or more substituents independently selected from C1-C6 alkyl, halo, —OMe, —CN, —NH2, and —NO2;
- and
- wherein at least one of R4, R5, R6, and R7 is A, J, Q, or X.
14 more elements
A method of treating a disease or disorder in a subject in need thereof comprising administering a modified indole alkaloid.
A method of enzymatically preparing an indole alkaloid, comprising:
- contacting a compound of Formula (Ia′) with an enzyme and a co-substrate;
- wherein the compound of Formula (Ia′) has a structure of:
- or a pharmaceutically acceptable salt thereof, wherein,
- R1 and R10 are independently selected from hydrogen, C1-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
- R8 is —CR′2—, wherein each R′ is independently selected from hydrogen, halo, haloalkyl, alkoxy, haloalkoxy, and amine;
- n is selected from 2, 3, and 4;
- R9 is selected from C2-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, —NO2, and 3- to 8-membered heterocycle, and wherein 3- to 8-membered heterocycle is optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
- R2 is selected from hydrogen, halogen, C1-C6 alkyl, and C1-C6 haloalkyl;
- R4, R5, R6, and R7 are each independently selected from hydrogen, —OH, and C1-C6 alkyl;
- and
- wherein at least one of R4, R5, R6, and R7 is —OH.
8 more elements
Dependencies are inferred from the claim text.